EUVIMEDEUVIMED entdecken
Crossref

Chronic Stress-Triggerable Nanoprodrugs Ameliorate Metabolic Abnormalities Driven by Hypothalamic-Pituitary-Adrenal Axis Dysregulation in Early Alzheimer’s Disease

Xiaomeng Yu, Fan Yang, Yining Liu, Jiyao Xie, Jiamei Xie, Yihan Chen, Jin Chang, Yan Dou

ACS Nano · 12.11.2026

DOI: 10.1021/acsnano.6c14806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 12.11.2026. Verfasst von Xiaomeng Yu und 7 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Tianjin Municipal Health Commission, National Natural Science Foundation of China, Tianjin Municipal Education Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic stress-induced dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is a crucial early risk factor that triggers brain energy metabolism disorders to accelerate the onset and progression of Alzheimer’s disease (AD). Herein, an amphiphilic precursor conjugate of ginsenoside Rc (Rc) covalently linked with a reactive oxygen species-sensitive thioketo bond is constructed to form stimuli-responsive prodrug assemblies, which are further modified with the TGN-Tet1 dual-ligand fusion peptide TPL to obtain a chronic stress-triggerable programmed nanoprodrug (TLRN). Following TPL-mediated blood-brain barrier penetration and neuronal preferential targeting, nanoprodrugs specifically disintegrate to selectively release active Rc in the chronic stress-induced excessive reactive oxygen species (ROS) microenvironment. Benefiting from the restoration of HPA axis homeostasis by normalizing glucocorticoid receptor nuclear translocation, TLRN treatment exhibits multifaceted rectification of cerebral metabolic abnormalities, including enhancing glucose uptake, promoting oxidative phosphorylation, and mitigating mitochondrial dysfunction. In young amyloid precursor protein/presenilin 1 (APP/PS1) transgenic mouse models exposed to chronic stress, this intervention can alleviate brain energy deprivation and amyloid-β (Aβ) accumulation, ultimately rescuing depressive-like behaviors and cognitive deficits, offering a promising approach for early prevention and flexible management of AD at high risk of chronic stress.

Förderung

  • Tianjin Municipal Health Commission
  • National Natural Science Foundation of China
  • Tianjin Municipal Education Commission

Zitieren

APA

Yu, X., Yang, F., Liu, Y., Xie, J., Xie, J., Chen, Y., Chang, J., & Dou, Y. (2026). Chronic Stress-Triggerable Nanoprodrugs Ameliorate Metabolic Abnormalities Driven by Hypothalamic-Pituitary-Adrenal Axis Dysregulation in Early Alzheimer’s Disease. ACS Nano. https://doi.org/10.1021/acsnano.6c14806

Vancouver

Yu X, Yang F, Liu Y, Xie J, Xie J, Chen Y, et al. Chronic Stress-Triggerable Nanoprodrugs Ameliorate Metabolic Abnormalities Driven by Hypothalamic-Pituitary-Adrenal Axis Dysregulation in Early Alzheimer’s Disease. ACS Nano. 2026. doi:10.1021/acsnano.6c14806

BibTeX
@article{Yu2026,
  author = {Yu, Xiaomeng and Yang, Fan and Liu, Yining and Xie, Jiyao and Xie, Jiamei and Chen, Yihan and Chang, Jin and Dou, Yan},
  title = {Chronic Stress-Triggerable Nanoprodrugs Ameliorate Metabolic Abnormalities Driven by Hypothalamic-Pituitary-Adrenal Axis Dysregulation in Early Alzheimer’s Disease},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c14806}
}
Kostenlos starten →